Vaxart

$7.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.71 (+11.17%) Today
-$0.12 (-1.62%) As of 10:38 PM UTC after-hours

Why Robinhood?

You can buy or sell Vaxart and other stocks, options, and ETFs commission-free!

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA. The listed name for VXRT is Vaxart, Inc Common Stock.

CEO
Andrei Floroiu
Employees
14
Headquarters
South San Francisco, California
Founded
2004
Market Cap
778.87M
Price-Earnings Ratio
Dividend Yield
Average Volume
19.35M
High Today
$7.13
Low Today
$6.01
Open Price
$6.61
Volume
12.76M
52 Week High
$17.49
52 Week Low
$0.266

Collections

VXRT Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.08 per share

You May Also Like